U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Source: ABC News 6
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clots
Published in Robesonia
More from RobesoniaMore posts in Robesonia »
- Biden signs a $95 billion war aid measure with assistance for Ukraine, Israel and Taiwan
- Wildfire burning in Wharton State Forest between Camden and Burlington counties in New Jersey
- Should teachers be armed? Tennessee passes bill that would allow school staff to carry concealed gun
- Driver charged with attempted homicide after allegedly hitting 5 people outside grocery store
- Supreme Court weighs whether states can ban abortion, even during some medical emergencies
Be First to Comment